Literature DB >> 30158844

Two Consecutive Pregnancies with Simpson-Golabi-Behmel Syndrome Type 1: Case Report and Review of Published Prenatal Cases.

Konstantin Ridnõi1,2, Elvira Kurvinen3, Sander Pajusalu2,3, Tiia Reimand2,4,3, Katrin Õunap2,3.   

Abstract

Fetal overgrowth and numerous congenital malformations can be detected in every trimester of pregnancy. New technologies in molecular testing, such as chromosomal microarray analysis and next-generation sequencing, continually demonstrate advantages for definitive diagnosis in fetal life. Simpson-Golabi-Behmel (SGB) syndrome is a rare but well-known overgrowth condition that is rarely diagnosed in the prenatal setting. We report 3 cases of SGB syndrome in 2 consecutive pregnancies. In our series, distinctive prenatal sonographic findings led to molecular diagnosis. Exome sequencing from fetal DNA revealed a hemizygous splice site variant in the GPC3 gene: NM_004484.3:c.1166+ 1G>T. The mother is a heterozygous carrier. We also provide an overview of the previously published 57 prenatal cases of SGB syndrome with prevalence estimation of the symptoms to aid prenatal differential diagnosis of fetal overgrowth syndromes.

Entities:  

Keywords:  Fetal overgrowth; GPC3; Prenatal symptoms; Simpson-Golabi-Behmel syndrome; Ultrasound

Year:  2018        PMID: 30158844      PMCID: PMC6108232          DOI: 10.1159/000490083

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  44 in total

1.  Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility.

Authors:  Dewi Astuti; Mark R Morris; Wendy N Cooper; Raymond H J Staals; Naomi C Wake; Graham A Fews; Harmeet Gill; Dean Gentle; Salwati Shuib; Christopher J Ricketts; Trevor Cole; Anthonie J van Essen; Richard A van Lingen; Giovanni Neri; John M Opitz; Patrick Rump; Irene Stolte-Dijkstra; Ferenc Müller; Ger J M Pruijn; Farida Latif; Eamonn R Maher
Journal:  Nat Genet       Date:  2012-02-05       Impact factor: 38.330

2.  Targeted prenatal diagnosis of Pallister-Killian syndrome.

Authors:  Anna Kucińska-Chahwan; Julia Bijok; Sylwia Dąbkowska; Anna Jóźwiak; Alicja Ilnicka; Beata Nowakowska; Grzegorz Jakiel; Tomasz Roszkowski
Journal:  Prenat Diagn       Date:  2017-03-27       Impact factor: 3.050

3.  Large gene panel sequencing in clinical diagnostics-results from 501 consecutive cases.

Authors:  S Pajusalu; T Kahre; H Roomere; Ü Murumets; L Roht; K Simenson; T Reimand; K Õunap
Journal:  Clin Genet       Date:  2017-08-21       Impact factor: 4.438

Review 4.  Silver-Russell Syndrome and Beckwith-Wiedemann Syndrome: Opposite Phenotypes with Heterogeneous Molecular Etiology.

Authors:  Katrin Õunap
Journal:  Mol Syndromol       Date:  2016-07-06

5.  A case of nondiabetic macrosomia with Simpson-Golabi-Behmel syndrome: antenatal sonographic findings.

Authors:  H Yamashita; I Yasuhi; T Ishimaru; T Matsumoto; T Yamabe
Journal:  Fetal Diagn Ther       Date:  1995 Mar-Apr       Impact factor: 2.587

6.  Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.

Authors:  G Pilia; R M Hughes-Benzie; A MacKenzie; P Baybayan; E Y Chen; R Huber; G Neri; A Cao; A Forabosco; D Schlessinger
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

7.  Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.

Authors:  K H Nicolaides; G Azar; D Byrne; C Mansur; K Marks
Journal:  BMJ       Date:  1992-04-04

Review 8.  Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement.

Authors:  Frédéric Brioude; Jennifer M Kalish; Alessandro Mussa; Alison C Foster; Jet Bliek; Giovanni Battista Ferrero; Susanne E Boonen; Trevor Cole; Robert Baker; Monica Bertoletti; Guido Cocchi; Carole Coze; Maurizio De Pellegrin; Khalid Hussain; Abdulla Ibrahim; Mark D Kilby; Malgorzata Krajewska-Walasek; Christian P Kratz; Edmund J Ladusans; Pablo Lapunzina; Yves Le Bouc; Saskia M Maas; Fiona Macdonald; Katrin Õunap; Licia Peruzzi; Sylvie Rossignol; Silvia Russo; Caroleen Shipster; Agata Skórka; Katrina Tatton-Brown; Jair Tenorio; Chiara Tortora; Karen Grønskov; Irène Netchine; Raoul C Hennekam; Dirk Prawitt; Zeynep Tümer; Thomas Eggermann; Deborah J G Mackay; Andrea Riccio; Eamonn R Maher
Journal:  Nat Rev Endocrinol       Date:  2018-01-29       Impact factor: 43.330

Review 9.  Prenatal molecular testing for Beckwith-Wiedemann and Silver-Russell syndromes: a challenge for molecular analysis and genetic counseling.

Authors:  Thomas Eggermann; Frédéric Brioude; Silvia Russo; Maria P Lombardi; Jet Bliek; Eamonn R Maher; Lidia Larizza; Dirk Prawitt; Irène Netchine; Marie Gonzales; Karen Grønskov; Zeynep Tümer; David Monk; Marcel Mannens; Krystyna Chrzanowska; Malgorzata K Walasek; Matthias Begemann; Lukas Soellner; Katja Eggermann; Jair Tenorio; Julián Nevado; Gudrun E Moore; Deborah Jg Mackay; Karen Temple; Gabriele Gillessen-Kaesbach; Tsutomu Ogata; Rosanna Weksberg; Elizabeth Algar; Pablo Lapunzina
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

10.  The Human Gene Mutation Database: 2008 update.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Howells; Andrew D Phillips; Nick St Thomas; David N Cooper
Journal:  Genome Med       Date:  2009-01-22       Impact factor: 11.117

View more
  2 in total

1.  A prenatal case of Simpson-Golabi-Behmel syndrome type 1 with a 0.26-Mb deletion fragment at Xq26.2 inherited from mother: Case report.

Authors:  Jing Sha; Fangfang Tan; Ying Liu; Zaochun Xu; Xuezhen Wang; Jingfang Zhai
Journal:  Medicine (Baltimore)       Date:  2022-04-22       Impact factor: 1.817

Review 2.  Prenatal case of Simpson-Golabi-Behmel syndrome with a de novo 370Kb-sized microdeletion of Xq26.2 compassing partial GPC3 gene and review.

Authors:  Jing Liu; Qin Liu; Shuting Yang; Na Ma; Jialun Pang; Ying Peng; Hui Xi; Zhengjun Jia; Yingchun Luo; Meiping Jiang; Yanling Teng; Wenxian Yu; Zhuo Li; Hua Wang
Journal:  Mol Genet Genomic Med       Date:  2021-07-22       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.